Vitamin E in the treatment of tardive dyskinesia.
Eight subjects with persistent tardive dyskinesia were treated with vitamin E and placebo in a randomized, double-blind crossover study. Their mean score on the Abnormal Involuntary Movement Scale (AIMS) was significantly lower after treatment with vitamin E than after placebo administration.
Elkashef
A M
AM
Department of Psychiatry, Baltimore VA Medical Center, MD.
Ruskin
P E
PE
Bacher
N
N
Barrett
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011618:Psychotic Disorders / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D014810:Vitamin E / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010919:Placebos; D014810:Vitamin E